Clinical Trial Update: Use of a GLP-1R Agonist to Treat Opioid Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluated a GLP-1 receptor agonist for opioid use disorder. The study is completed and results were posted on 2024-11-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Opiate Substitution Treatment, Opioid-Related Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-06